40 participants
Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-02
- Start Date:
- 2006-04-30
- Completion:
- 2013-02-28
Conditions
- Breast Cancer
- Neoplasm Metastasis
Interventions
- DRUG